CHRONIC HEPATITIS B LIVER FIBROSIS

Clinical trials for CHRONIC HEPATITIS B LIVER FIBROSIS explained in plain language.

Never miss a new study

Get alerted when new CHRONIC HEPATITIS B LIVER FIBROSIS trials appear

Sign up with your email to follow new studies for CHRONIC HEPATITIS B LIVER FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Scientists test drug mix safety for liver patients

Knowledge-focused Not yet recruiting

This early study aims to understand how a new drug for liver scarring (hydronidone) interacts with four common hepatitis B medications when taken together. Researchers will measure drug levels in the blood of 64 healthy Chinese volunteers to see if the drugs affect each other. Th…

Matched conditions: CHRONIC HEPATITIS B LIVER FIBROSIS

Phase: PHASE1 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Knowledge-focused

Last updated Mar 19, 2026 14:55 UTC

CHRONIC HEPATITIS B LIVER FIBROSIS

Get alerted when new CHRONIC HEPATITIS B LIVER FIBROSIS trials appear

Scientists test drug mix safety for liver patients